Preventive Effect of Trimidox on Oxidative Stress in U937 Cell Line(Pharmacology)
スポンサーリンク
概要
- 論文の詳細を見る
Trimidox (3,4,5-trihydroxybenzamidoxime) is one of the most potent ribonucleotide reductase inhibitors, revealing an antitumor effect in several experimental studies. We have examined the effect of trimidox on the induction of cytotoxicity and apoptosis via oxidative stress by typical free radical inducers, hydrogen peroxide (H_2O_2), tert-butylhydroperoxide (tBuOOH) or ultraviolet (UV) irradiation in a human diffuse histiocytic lymphoma U937 cell line. Trimidox showed strong radical scavenging activity by the DPPH reduction assay. The 50% rate inhibited the DPPH reduction concentration of trimidox, and its derivates didox, or gallic acid were 8.8 μM, 117.5 μM, or 41.8 μM, respectively. Induction of cytotoxicity by H_2O_2 (500 μM) or tBuOOH (100 μM) was concentration-dependently attenuated by incubation with Trimidox (10-150 μM). Trimidox also prevented the effect of UV-induced apoptosis estimated by both nuclear morphological change and DNA fragmentation. This effect was due to inhibition of the production of reactive oxygen species. Moreover, the activity and mRNA expression of catalase, an antioxidant enzyme, was significantly increased by trimidox. These results indicate that trimidox has radical scavenging activity and prevents exogenous oxidative stress and increase in catalase; therefore, trimidox is suggested as an anticancer agent exhibiting potent antioxidant properties in this study.
- 公益社団法人日本薬学会の論文
- 2007-05-01
著者
-
ISHIKAWA Masaaki
Department of Pharmacology and Toxicology, Cancer Research Institute, Tohoku Pharmaceutical Universi
-
KANNO Syu-ichi
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
KITAJIMA Yasue
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
KAKUTA Mai
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
OSANAI Yuu
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
KURAUCHI Kaori
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
UJIBE Mayuko
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
Kakuta Mai
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Osanai Yuu
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Ujibe Mayuko
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Kanno Syu-ichi
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Kanno Syu-ichi
東北薬科大学癌研究所
-
Kimura Katsuhiko
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Kitajima Yasue
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Kanno Syu-ichi
東北薬科大学 薬物治療学教室
-
OHTAKE Takaharu
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
TAKESHITA Mitsuhiro
Department of Phamacology and Pharmacy, Cancer Research Institute
-
Kanno Syu-ichi
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku Pharmaceutical University
-
UWAI Kouji
Department of Pharmaceutics, Tohoku Pharmaceutical University
-
Ishikawa Masaaki
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Ishikawa Masaaki
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku Pharmaceutical University
-
Ishikawa Masaaki
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku College Of Pharmacy
-
Uwai Kohji
Department Of Pharmacology Tohoku Pharmaceutical University
-
Koiwai Kimiko
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku Pharmaceutical University
-
Ohtake Takaharu
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Ishikawa Masaaki
Dep. Of Clinical Pharmacotheraputics Tohoku Pharmaceutical Univ. Jpn
-
Takeshita Mitsuhiro
Department Of Pharmacology Tohoku Pharmaceutical University
関連論文
- Costunolide-Induced Apoptosis Is Caused by Receptor-Mediated Pathway and Inhibition of Telomerase Activity in NALM-6 Cells(Pharmacology)
- Anti-inflammatory Effect of Propolis through Inhibition of Nitric Oxide Production on Carrageenin-Induced Mouse Paw Edema(Pharmacology)
- Early Gastric Cancer Associated with Synchronous Liver Metastasis and Portal Tumorous Embolism : Report of a Case
- Trimidox-Induced Apoptosis Is Mediated Through Induction of p53 in NALM-6 Cells
- Inhibitory Effect of Propolis on the Growth of Human Leukemia U937 (Toxicology)
- Resistance to Ara-C Up-Regulates the Activation of NF-κB, Telomerase Activity and Fas Expression in NALM-6 Cells(Pharmacology)
- Circumvention of Acquired Resistance to Doxorubicin in K562 Human Leukemia Cells by Oxatomide
- Reversal of Vinblastine Resistance in Human Leukemic Cells by Haloperidol and Dihydrohaloperidol
- Potentiation of Acetaminophen Hepatotoxicity by Doxapram in Mouse Primary Cultured Hepatocytes
- Reversal of Multidrug Resistance in Human Leukemia K562 by Tamolarizine, a Novel Calcium Antagonist